John Moriarty
Fortune : 994 863 $ au 31/07/2026
Fortune : 994 863 $ au 31/07/2026
John B. Moriarty is Secretary & Trustee at American Kidney Fund, Inc. since 2015 and Secretary & Chief Legal Officer at Kardigan, Inc. starting in 2026.
Former roles include Executive Director & Senior Counsel at Amgen, Inc. from 2002 to 2008; Chief Legal Officer & General Counsel at Elan Corp.
Plc from 2008 to 2012; Executive Vice President & General Counsel at Alexion Pharmaceuticals, Inc. from 2014 to 2018; Secretary, Executive VP & General Counsel at Portola Pharmaceuticals LLC from 2018 to 2020; Senior Vice President & General Counsel at Elan Pharmaceuticals LLC; Secretary, Chief Legal Officer & Executive VP at Olema Pharmaceuticals, Inc. from 2020 to 2023; Secretary, Chief Legal Officer & Executive VP at Mirati Therapeutics, Inc. from 2023 to 2024; and Secretary & Chief Legal Officer at Avidity Biosciences, Inc. from 2024 to 2026.
Education includes undergraduate studies at the University of Virginia and graduate studies at the University of Georgia School of Law.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
0,05% | 17/06/2026 | 47 784 ( 0,05% ) | 994 863 $ | 31/07/2026 |
| Sociétés | Poste | Début |
|---|---|---|
American Kidney Fund, Inc.
American Kidney Fund, Inc. Medical/Nursing ServicesHealth Services Provides treatment & financial assistance to kidney patients | Directeur/Membre du Conseil | 01/01/2015 |
| Sociétés | Poste | Fin |
|---|---|---|
| AVIDITY BIOSCIENCES, INC. | Conseiller Juridique Général | 27/02/2026 |
| MIRATI THERAPEUTICS | Conseiller Juridique Général | 23/01/2024 |
| OLEMA PHARMACEUTICALS, INC. | Conseiller Juridique Général | 01/05/2023 |
| PORTOLA PHARMACEUTICALS, INC. | Conseiller Juridique Général | 01/07/2020 |
| ALEXION PHARMACEUTICALS, INC. | Conseiller Juridique Général | 01/02/2018 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 11 |
|---|---|
Amgen, Inc.
Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Elan Corp. Plc
Elan Corp. Plc Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals and drug delivery systems | Health Technology |
Alexion Pharmaceuticals, Inc.
Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops life-changing therapies for people living with rare disorders | Health Technology |
Portola Pharmaceuticals LLC
Portola Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Engages in development and commercialization of novel therapeutics | Health Technology |
Elan Pharmaceuticals LLC
Elan Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Avidity Biosciences, Inc.
Avidity Biosciences, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that provides research and development, administrative & investment services | Health Technology |
University of Virginia
University of Virginia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Mirati Therapeutics, Inc.
Mirati Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops cancer therapies | Health Technology |
American Kidney Fund, Inc.
American Kidney Fund, Inc. Medical/Nursing ServicesHealth Services Provides treatment & financial assistance to kidney patients | Health Services |
University of Georgia School of Law
University of Georgia School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Olema Pharmaceuticals, Inc.
Olema Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs for the treatment & prevention of estrogen receptor positive breast cancer | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national